TS Financial Group (TSFG)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

TS Financial Group (TSFG)’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100	Closed	-$2K	–	940
2021 Q3	$2K	Buy	+100	New	+$2.76K	﹤0.01%	778

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

TS Financial Group (TSFG)'s DRNA Position: Q4 2021 in Review

TS Financial Group (TSFG) sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 100 shares — an estimated $2K sold.

TS Financial Group (TSFG) first reported a position in DRNA in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

TS Financial Group (TSFG) reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
TS Financial Group (TSFG) sold 100 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $2K.
TS Financial Group (TSFG) first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
TS Financial Group (TSFG)'s Dicerna Pharmaceuticals, Inc. position peaked at $2K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2021, filed 10 Feb 2022.